Search Results - I. A. Karput

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Allelic variant 6A (rs35068180) of the MMP-3 promoter region as a predictor of cardiotoxicity after the end of adjuvant chemotherapy with doxorubicin in patients with breast cancer

    Allelic variant 6A (rs35068180) of the MMP-3 promoter region as a predictor of cardiotoxicity after the end of adjuvant chemotherapy with doxorubicin in patients with breast cancer by I. A. Karput, V. A. Snezhitsky, M. N. Kurbat, O. A. Gorustovich, O. S. Babenko

    Published 2024-02-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Molecular genetic indicators of the probability of early myocardial systolic dysfunction signs in doxorubicin chemotherapy in patients with breast cancer of moderate and low HFA-ICOS risk groups

    Molecular genetic indicators of the probability of early myocardial systolic dysfunction signs in doxorubicin chemotherapy in patients with breast cancer of moderate and low HFA-IC... by I. A. Karput, V. A. Snezhitsky, M. N. Kurbat, O. A. Gorustovich, A. V. Kopytsky, A. S. Babenko

    Published 2024-11-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Changes in left ventricular systolic and diastolic function after chemotherapy for breast cancer with doxorubicin

    Changes in left ventricular systolic and diastolic function after chemotherapy for breast cancer with doxorubicin by I. A. Karput, V. A. Snezhitskii, M. N. Kurbat, V. A. Gorustovich, Yu. I. Karpovich, A. Yu. Rubinskii, T. A. Smirnova, A. S. Babenka

    Published 2024-01-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: